TERACT Adjusts Financial Calendar for H1 Results

Paris-based TERACT has revised its financial calendar. The company will now publish its consolidated H1 2025-2026 results earlier than planned, advancing the date from March 19, 2026, to March 4, 2026. This change aligns with the proposed public offer and potential squeeze-out by the InViVo Group and the Founders' companies. The move ensures transparency and aligns with regulatory considerations.

Should the squeeze-out occur as scheduled on May 19, 2026, it may influence subsequent financial disclosures, potentially exempting TERACT from its annual revenue and results publications initially set for July 28 and October 8, 2026. These adjustments reflect the strategic maneuvers related to the takeover activity underway.